IL18 and renal cell carcinoma: The results demonstrated that the basal IL-18 levels were significantly higher in RCC patients (212.80 ± 21.39 pg/mL) than those of control subjects (113.70 ± 9.94 pg/mL) (p = 0.0001) (Figure 5).